Bortezomib [clinicaltrials_resource:37f09d074cdfece58a13090b4d988946]
intervention [clinicaltrials_vocabulary:intervention]
Bortezomib [clinicaltrials_resource:37f09d074cdfece58a13090b4d988946]
Bio2RDF identifier
37f09d074cdfece58a13090b4d988946
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:37f09d074cdfece58a13090b4d988946
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
1.3 mg/m^2 by intravenous pyelogram (IVP) over 3-5 seconds on days 1, 4, 8 and 11.
intervention name [clinicaltrials_vocabulary:intervention-name]
Bortezomib
other name [clinicaltrials_vocabulary:other-name]
Velcade(R)
identifier
clinicaltrials_resource:37f09d074cdfece58a13090b4d988946
title
Bortezomib
@en
type
label
Bortezomib [clinicaltrials_resource:37f09d074cdfece58a13090b4d988946]
@en